Story
Apnimed IPO Poised to Price in Upper Half of Range on Strong Demand, Report Says
Apnimed Inc., a developer of drugs for sleep-related breathing disorders, is on track to price its initial public offering in the upper portion of its marketed range, according to a Bloomberg report published Thursday. The strong investor appetite suggests the offering could price between $15 and $16 per share, surpassing the midpoint of its initial $14 to $16 target.
Significant Investor Interest
The positive pricing outlook is reportedly fueled by robust demand from investors. The report indicates that the IPO has been oversubscribed, with orders for multiple times the number of shares being offered.
Notably, the offering has attracted large orders from long-only investors. This type of institutional interest can be a key indicator of confidence in a company's long-term fundamentals, as opposed to short-term trading speculation.
Offering and Trading Details
AdApnimed is expected to finalize the IPO pricing later on Thursday. The company's shares are slated to begin trading on the Nasdaq Global Market on Friday under the ticker symbol APMD.
The banks managing the public offering include:
- Bank of America Corp.
- Evercore Inc.
- Cantor Fitzgerald
- LifeSci Capital
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.